Mandaviya meets WHO official for Covaxin approval

Tribune News Service

Updated At : 10:44 AM Aug 13, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, August 12

Health Minister Mansukh Mandaviya on Thursday met WHO chief scientist and former director general of ICMR Soumya Swaminathan and discussed the issue of WHO emergency use approval for India-made Covid-19 vaccine, Covaxin.

“We had a productive discussion on WHO’s approval for Covaxin. @DoctorSoumya also appreciated India’s efforts for containment of #Covid-19,” Mandaviya tweeted later.

Bharat Biotech in collaboration with ICMR-National Institute of Virology, Pune, had on July 9 completed all formalities with respect to submission of documents and safety data for Covaxin approvals. The WHO’s application processing timeline is up to six weeks. Sources said Covaxin approval could come by August end. — TNS

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles